Abstract: Composition and method of use for tannin based environmentally benign polymeric coagulants are disclosed. Tannin based coagulants are copolymers of naturally occurring tannins and a cationic monomer. One embodiment of the present invention provides for a composition, of a tannin based polymeric coagulant which is comprised of N,N-(dimethylaminoethyl) methacrylate (MADAME) polymerized using t-butylhydroperoxide and sodium metabisulfite. The resulting polyMADAME is converted to hydrochloride and then blended/reacted in an aqueous medium with tannin to obtain a homogenous poly(MADAME)-tannin composition. The method of use comprises adding an amount of the composition effective for the purpose of clarifying oily wastewater from food and beverage, steel, automotive, transportation, refinery, pharmaceutical, metals, paper and pulp, chemical processing and hydrocarbon processing industries.

Abstract: Composition and method of use for tannin based environmentally benign polymeric coagulants are disclosed. Tannin based coagulants are copolymers of naturally occurring tannins and a cationic monomer. One embodiment of the present invention provides for a composition of a tannin based polymeric coagulant which is comprised of N,N-(dimethylaminoethyl)methacrylate (MADAME) polymerized using t-butylhydroperoxide and sodium metabisulfite. The resulting polyMADAME is converted to hydrochloride and then blended/reacted in an aqueous medium with tannin to obtain a homogenous poly(MADAME)-Tannin composition. The method of use comprises adding an amount of the composition effective for the purpose of clarifying oily wastewater from food and beverage, steel, automotive, transportation, refinery, pharmaceutical, metals, paper and pulp, chemical processing and hydrocarbon processing industries.

Abstract: Tannin based environmentally friendly polymeric coagulants are disclosed which are copolymers of naturally occurring tannins, dialdehyde and diamines. In a preferred embodiment, the dialdehyde is glyoxal and the diamine is dimethylamino propylamine.

Abstract: Disclosed is a method for removing a neutral or an ionic guanidine compound from aqueous media optionally comprising an alkali metal halide, wherein the method is selected from the group consisting of (a) adsorption onto a carbonaceous adsorbent, (b) adsorption onto a clay adsorbent, (c) filtration through a nanofiltration membrane, and (d) removal of water and calcination.

Abstract: A process for forming a cycloalkylidene bisphenol comprises: reacting a cycloalkanone compound of formula: where [A] is a substituted or an unsubstituted aromatic group, R1-R4 independently represent a hydrogen or a C1-C12 hydrocarbyl group; and “a” and “b” are integers independently having values from 0-3; with an aromatic hydroxy compound of formula [A]-OH, where [A] is as previously described; at a mole ratio of greater than or equal to about 20, in the presence of a sulfonic acid type ion exchange resin catalyst crosslinked with greater than or equal to about 8 weight percent of divinylbenzene, and a promoter selected from the group consisting of a mercaptan compound and a resorcinol compound; to form a cycloalkylidene bisphenol of formula: where [A], R1-R4, “a” and “b” are as previously described. Moreover, any acid catalyst can be used with a resorcinol promoter.

Abstract: Disclosed is a method for removing a neutral or an ionic guanidine compound from an aqueous media optionally comprising an alkali metal halide, wherein the method is selected from the group consisting of (a) adsorption onto a carbonaceous adsorbent, (b) adsorption onto a clay adsorbent, (c) filtration through a nanofiltration membrane, and (d) removal of water and calcination.

Abstract: A method for purifying 1,1-bis(4′-hydroxy-3′-methylphenyl)cyclohexane comprises dissolving said 1,1-bis(4′-hydroxy-3′-methylphenyl)cyclohexane in a first solvent consisting essentially of an alcohol to form a first solution; filtering said first solution; adding a second solvent consisting essentially of water to the filtered first solution to form a second solution, wherein said second solution comprises about 40 parts to about 95 parts of the first solvent per 100 parts of the combined weight of the first and second solvents; crystallizing said 1,1-bis(4′-hydroxy-3′-methylphenyl) cyclohexane from said second solution to form a first crystalline product; dissolving said first crystalline product in a third solvent to form a third solution, wherein the third solvent comprises an aromatic compound; and crystallizing said 1,1-bis(4′-hydroxy-3′-methylphenyl)cyclohexane from said third solution to produce a second crystalline product.